TSE:ARZ

Aralez Pharmaceuticals Competitors

Add
Compare
Today's Range N/A
50-Day Range
C$0.43
MA: C$0.43
C$0.43
52-Week Range N/A
Volume274,400 shs
Average Volume79,103 shs
Market CapitalizationC$28.89 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Aralez Pharmaceuticals (TSE:ARZ) Vs. ANX, F, LN, TML, THX, and DNG

Should you be buying ARZ stock or one of its competitors? Companies in the industry of "gold" are considered alternatives and competitors to Aralez Pharmaceuticals, including Anaconda Mining (ANX), Fiore Gold (F), Loncor Resources (LN), Treasury Metals (TML), Thor Explorations (THX), and Dynacor Gold Mines (DNG).

Anaconda Mining (TSE:ANX) and Aralez Pharmaceuticals (TSE:ARZ) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Valuation and Earnings

This table compares Anaconda Mining and Aralez Pharmaceuticals' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anaconda MiningC$41.58 million2.77C$9.29 millionC$0.0612.41
Aralez PharmaceuticalsN/AN/AN/AN/AN/A

Anaconda Mining has higher revenue and earnings than Aralez Pharmaceuticals.

Profitability

This table compares Anaconda Mining and Aralez Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Anaconda MiningN/AN/AN/A
Aralez PharmaceuticalsN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations for Anaconda Mining and Aralez Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Anaconda Mining00203.00
Aralez Pharmaceuticals0000N/A

Summary

Anaconda Mining beats Aralez Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

Fiore Gold (CVE:F) and Aralez Pharmaceuticals (TSE:ARZ) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability and dividends.

Profitability

This table compares Fiore Gold and Aralez Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fiore GoldN/AN/AN/A
Aralez PharmaceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Fiore Gold and Aralez Pharmaceuticals, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fiore Gold00103.00
Aralez Pharmaceuticals0000N/A

Fiore Gold currently has a consensus target price of C$2.25, indicating a potential upside of 84.43%.

Valuation & Earnings

This table compares Fiore Gold and Aralez Pharmaceuticals' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fiore GoldC$82.05 million1.45C$25.60 millionC$0.264.66
Aralez PharmaceuticalsN/AN/AN/AN/AN/A

Fiore Gold has higher revenue and earnings than Aralez Pharmaceuticals.

Summary

Fiore Gold beats Aralez Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

Aralez Pharmaceuticals (TSE:ARZ) and Loncor Resources (TSE:LN) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Aralez Pharmaceuticals and Loncor Resources, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aralez Pharmaceuticals0000N/A
Loncor Resources00014.00

Loncor Resources has a consensus target price of C$1.18, indicating a potential upside of 40.48%.

Profitability

This table compares Aralez Pharmaceuticals and Loncor Resources' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aralez PharmaceuticalsN/AN/AN/A
Loncor ResourcesN/AN/AN/A

Valuation and Earnings

This table compares Aralez Pharmaceuticals and Loncor Resources' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aralez PharmaceuticalsN/AN/AN/AN/AN/A
Loncor ResourcesN/AN/AN/AC($0.02)-40.00

Summary

Loncor Resources beats Aralez Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Treasury Metals (TSE:TML) and Aralez Pharmaceuticals (TSE:ARZ) are both small-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for Treasury Metals and Aralez Pharmaceuticals, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Treasury Metals00103.00
Aralez Pharmaceuticals0000N/A

Treasury Metals currently has a consensus price target of C$2.00, suggesting a potential upside of 124.72%.

Profitability

This table compares Treasury Metals and Aralez Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Treasury MetalsN/AN/AN/A
Aralez PharmaceuticalsN/AN/AN/A

Valuation & Earnings

This table compares Treasury Metals and Aralez Pharmaceuticals' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treasury MetalsC$-73.00-1,371,965.48C$-3,938,620.00C($0.04)-25.43
Aralez PharmaceuticalsN/AN/AN/AN/AN/A

Aralez Pharmaceuticals has higher revenue and earnings than Treasury Metals.

Thor Explorations (CVE:THX) and Aralez Pharmaceuticals (TSE:ARZ) are both small-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Analyst Ratings

This is a summary of current ratings and recommmendations for Thor Explorations and Aralez Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Thor Explorations0000N/A
Aralez Pharmaceuticals0000N/A

Profitability

This table compares Thor Explorations and Aralez Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Thor ExplorationsN/AN/AN/A
Aralez PharmaceuticalsN/AN/AN/A

Earnings and Valuation

This table compares Thor Explorations and Aralez Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thor ExplorationsN/AN/AN/AC($0.01)-24.00
Aralez PharmaceuticalsN/AN/AN/AN/AN/A

Dynacor Gold Mines (TSE:DNG) and Aralez Pharmaceuticals (TSE:ARZ) are both small-cap basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Earnings and Valuation

This table compares Dynacor Gold Mines and Aralez Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynacor Gold MinesC$101.53 million0.87C$4.28 millionC$0.1120.73
Aralez PharmaceuticalsN/AN/AN/AN/AN/A

Dynacor Gold Mines has higher revenue and earnings than Aralez Pharmaceuticals.

Analyst Ratings

This is a summary of current ratings and recommmendations for Dynacor Gold Mines and Aralez Pharmaceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Dynacor Gold Mines0000N/A
Aralez Pharmaceuticals0000N/A

Profitability

This table compares Dynacor Gold Mines and Aralez Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Dynacor Gold MinesN/AN/AN/A
Aralez PharmaceuticalsN/AN/AN/A

Summary

Dynacor Gold Mines beats Aralez Pharmaceuticals on 1 of the 1 factors compared between the two stocks.


Aralez Pharmaceuticals Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ANX
Anaconda Mining
0.9$0.72flatC$115.33 millionC$41.58 million12.41
F
Fiore Gold
1.4$1.22flatC$104.56 millionC$82.05 million4.66News Coverage
LN
Loncor Resources
1.4$0.84flatC$100.22 millionN/A-40.00Gap Down
TML
Treasury Metals
1.8$0.89flatC$100.15 millionC$-73.00-25.43Gap Up
THX
Thor Explorations
0.6$0.24flatC$98.22 millionN/A-24.00
DNG
Dynacor Gold Mines
1.5$2.28flatC$89.39 millionC$101.53 million20.73Dividend Announcement
AU
Aurion Resources
1.6$0.86flatC$86.90 millionC$-2,049.00-13.23
BTR
Bonterra Resources
0.9$1.20flatC$80.61 millionC$5.78 million-12.77
SSP
Sandspring Resources
0.6$0.26flatC$75.38 millionN/A-7.73Gap Down
GWM
Galway Metals
1.7$0.95flatC$72.13 millionN/A-15.32
RVG
Revival Gold
1.3$0.65flatC$71.81 millionN/A-4.42
NHK
Nighthawk Gold
1.6$1.17flatC$71.46 millionN/A-4.37
OM
Osisko Metals
0.9$0.44flatC$70.20 millionN/A-12.79
Superior Gold logo
SGI
Superior Gold
1.2$0.70flatC$68.48 millionC$106.15 million-11.11Analyst Revision
News Coverage
TSG
TriStar Gold
1.2$0.26flatC$64.72 millionN/A-18.57News Coverage
PBR
Soma Gold Corp. (PBR.V)
0.6$0.02flatC$60.79 millionN/A-0.19High Trading Volume
Gap Up
Primero Mining logo
P
Primero Mining
0.5N/AN/AC$58.88 millionN/A0.00
PGLC
Pershing Gold
0.5N/AN/AC$56.50 millionN/A-3.98Gap Up
GBAR
Monarch Mining
1.7$0.79flatC$56.25 millionN/A0.00
XTG
Xtra-Gold Resources
0.5$1.17flatC$54.37 millionN/A29.25News Coverage
ESM
Euro Sun Mining
0.5$0.33flatC$53.47 millionN/A-2.90
QMX
QMX Gold
0.7$0.29flatC$53.18 millionN/A-29.00
KER
Kerr Mines Inc. (KER.TO)
1.3N/AN/AC$48.45 millionN/A-4.63
VLC
Velocity Minerals
0.4$0.45flatC$46.97 millionN/A-25.00News Coverage
Gap Up
RYR
Royal Road Minerals
0.4$0.37flatC$45.69 millionN/A-13.52
ATC
ATAC Resources
0.5$0.17flatC$44.25 millionN/A-0.27Gap Down
GPG
Grande Portage Resources
0.5$0.30flatC$43.01 millionN/A-18.75Gap Down
GRC
Gold Springs Resource
1.7$0.11flatC$41.87 millionN/A-21.00Gap Up
TMI
TriMetals Mining
0.5$0.12flatC$41.87 millionN/A-2.40
KG
Klondike Gold
0.6$0.23flatC$40.81 millionN/A-32.14Gap Down
MGM
Maple Gold Mines
0.3$0.35flatC$40.66 millionN/A-20.59Gap Down
RGD
Reunion Gold
0.9$0.08flatC$34.56 millionN/A-3.13Gap Up
CCM
Canagold Resources
0.7$0.48flatC$34.49 millionN/A-14.55
GFG
GFG Resources
1.0$0.16flatC$33.80 millionN/A-40.00High Trading Volume
News Coverage
BTU
BTU Metals
0.5$0.13flatC$33.56 millionN/A-18.57Gap Up
ECR
Cartier Resources
0.9$0.30flatC$33.54 millionN/A-100.00
AGG
African Gold Group
1.2$0.18flatC$33.31 millionC$-242.00-2.57High Trading Volume
News Coverage
RML
Rusoro Mining
0.5$0.07flatC$32.69 millionN/A-1.81Gap Down
TXR
TerraX Minerals
0.5$0.28flatC$31.32 millionN/A-25.45High Trading Volume
SSV
Southern Silver Exploration
1.4$0.41flatC$31.08 millionN/A18.41News Coverage
SCA
Savary Gold
0.4$0.12flatC$29.53 millionN/A-57.50Gap Up
CLH
Coral Gold Resources Ltd. (CLH.V)
0.5$1.11flatC$28.74 millionN/A-138.75High Trading Volume
Abcourt Mines logo
ABI
Abcourt Mines
0.9$0.14flatC$27.66 millionC$26.22 million23.33Gap Up
LME
Laurion Mineral Exploration
1.3$0.25flatC$27.25 millionN/A-14.41News Coverage
Gap Down
CGLD
Core Gold
0.4$0.16flatC$26.70 millionC$22.79 million-7.62Gap Up
EVM
Orogen Royalties Inc. (EVM.V)
0.5$0.51flatC$25.59 millionC$88,193.00-13.78Gap Down
ELO
Eloro Resources
0.5$3.85flatC$24.88 millionN/A-96.25News Coverage
NUG
NuLegacy Gold
1.0$0.15flatC$24.43 millionN/A-29.00
AZX
Alexandria Minerals
0.8$0.05flatC$23.93 millionN/A-3.46
SPA
Spanish Mountain Gold
0.7$0.27flatC$23.86 millionN/A-132.50
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at conta[email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.